These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36194187)

  • 1. Intrapyloric botulinum toxin injection for functional nausea and vomiting: Just a placebo?
    Bolia R
    Neurogastroenterol Motil; 2022 Dec; 34(12):e14479. PubMed ID: 36194187
    [No Abstract]   [Full Text] [Related]  

  • 2. Botulinum toxin A for the treatment of delayed gastric emptying.
    Friedenberg FK; Palit A; Parkman HP; Hanlon A; Nelson DB
    Am J Gastroenterol; 2008 Feb; 103(2):416-23. PubMed ID: 18070232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrapyloric Botulinum Toxin Injection for Refractory Nausea and Vomiting in Pediatric Patients.
    Osgood PT; Essner BS; Fountain L; Sullivan EC; Meegan C; Fortunato JE
    J Pediatr Gastroenterol Nutr; 2023 Dec; 77(6):726-733. PubMed ID: 37794574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endoscopic pyloric injection of botulinum toxin A for the treatment of refractory gastroparesis.
    Bromer MQ; Friedenberg F; Miller LS; Fisher RS; Swartz K; Parkman HP
    Gastrointest Endosc; 2005 Jun; 61(7):833-9. PubMed ID: 15933684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoscopic intrapyloric injection of botulinum toxin A in the treatment of children with gastroparesis: a retrospective, open-label study.
    Rodriguez L; Rosen R; Manfredi M; Nurko S
    Gastrointest Endosc; 2012 Feb; 75(2):302-9. PubMed ID: 22248598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective study of intrapyloric botulinum toxin and EndoFLIP in children with nausea and vomiting.
    Hirsch S; Nurko S; Liu E; Rosen R
    Neurogastroenterol Motil; 2022 Nov; 34(11):e14428. PubMed ID: 35811408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of intrapyloric botulinum toxin injection on gastric emptying and meal-related symptoms in gastroparesis patients.
    Arts J; van Gool S; Caenepeel P; Verbeke K; Janssens J; Tack J
    Aliment Pharmacol Ther; 2006 Aug; 24(4):661-7. PubMed ID: 16907899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyloric injection of botulinum toxin for treatment of diabetic gastroparesis.
    Ezzeddine D; Jit R; Katz N; Gopalswamy N; Bhutani MS
    Gastrointest Endosc; 2002 Jun; 55(7):920-3. PubMed ID: 12024156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The treatment of diabetic gastroparesis with botulinum toxin injection of the pylorus.
    Lacy BE; Crowell MD; Schettler-Duncan A; Mathis C; Pasricha PJ
    Diabetes Care; 2004 Oct; 27(10):2341-7. PubMed ID: 15451898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin type A for the treatment of gastroparesis in Parkinson's disease patients.
    Gil RA; Hwynn N; Fabian T; Joseph S; Fernandez HH
    Parkinsonism Relat Disord; 2011 May; 17(4):285-7. PubMed ID: 21296606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic review on intrapyloric botulinum toxin injection for gastroparesis.
    Bai Y; Xu MJ; Yang X; Xu C; Gao J; Zou DW; Li ZS
    Digestion; 2010; 81(1):27-34. PubMed ID: 20029206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reply: Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: randomized, double-blind, noninferiority trial.
    Mueller J
    Mov Disord; 2009 May; 24(7):1098-9; author reply 1100. PubMed ID: 18942082
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical trial: a randomized-controlled crossover study of intrapyloric injection of botulinum toxin in gastroparesis.
    Arts J; Holvoet L; Caenepeel P; Bisschops R; Sifrim D; Verbeke K; Janssens J; Tack J
    Aliment Pharmacol Ther; 2007 Nov; 26(9):1251-8. PubMed ID: 17944739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beyond gastric emptying: a "toxic" lesson about gastroparesis.
    Pasricha PJ
    Am J Gastroenterol; 2008 Feb; 103(2):424-6. PubMed ID: 18289204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New therapeutic approaches to diabetic gastroparesis].
    Hummel M; Geigenberger G; Brand J; Ziegler AG; Füchtenbusch M
    Med Klin (Munich); 2008 Jul; 103(7):514-8. PubMed ID: 18604486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum toxin type A for treatment of refractory gastroparesis.
    DeSantis ER; Huang S
    Am J Health Syst Pharm; 2007 Nov; 64(21):2237-40. PubMed ID: 17959574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyloric sphincter therapy: botulinum toxin, stents, and pyloromyotomy.
    Clarke JO; Snape WJ
    Gastroenterol Clin North Am; 2015 Mar; 44(1):127-36. PubMed ID: 25667028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of endoscopic pyloric therapies for patients with nausea and vomiting and functional obstructive gastroparesis.
    Wellington J; Scott B; Kundu S; Stuart P; Koch KL
    Auton Neurosci; 2017 Jan; 202():56-61. PubMed ID: 27460691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyloric distensibility measurement predicts symptomatic response to intrapyloric botulinum toxin injection.
    Desprez C; Melchior C; Wuestenberghs F; Zalar A; Jacques J; Leroi AM; Gourcerol G
    Gastrointest Endosc; 2019 Nov; 90(5):754-760.e1. PubMed ID: 31028783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Commentary: Botulinum toxin in clinical medicine: part II.
    Benedetto AV
    Clin Dermatol; 2004; 22(1):1-2. PubMed ID: 15158537
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.